Short description: Chemical compound
Etofylline nicotinate |
| Clinical data |
|---|
| ATC code | |
|---|
| Identifiers |
|---|
2-(1,3-Dimethyl-2,6-dioxopurin-7-yl)ethyl pyridine-3-carboxylate
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| Chemical and physical data |
|---|
| Formula | C15H15N5O4 |
|---|
| Molar mass | 329.316 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CCOC(=O)c3cccnc3
|
InChI=1S/C15H15N5O4/c1-18-12-11(13(21)19(2)15(18)23)20(9-17-12)6-7-24-14(22)10-4-3-5-16-8-10/h3-5,8-9H,6-7H2,1-2H3 Key:ZWIAODBBEZGVPY-UHFFFAOYSA-N
|
| (verify) |
Etofylline nicotinate is a vasodilator.[1]
References
- ↑ "Quantitative Structure Vasodilatory Activity Relationship – Synthesis and "In Silico" and "In Vitro" Evaluation of Resveratrol-Coumarin Hybrids". QSAR & Combinatorial Science 26 (3): 317–332. 9 March 2007. doi:10.1002/qsar.200630006.
 | Original source: https://en.wikipedia.org/wiki/Etofylline nicotinate. Read more |